January 2017NEW YEAR, NEW GENE DISCOVERYNew gene found, meaning potential for new avenues of research, and hope for those families yet without a genetic diagnosis…
December 2016HUGE IMPACT FROM BANK OF ENGLAND FUNDRAISINGOver £250,000 raised by generous Bank staff for two Charities of the Year, one of which is the Trust…
December 2016WEDDING FAVOURSSarah and Mark very kindly donated to the Trust this autumn, in lieu of wedding favours…
November 2016CORPORATE SUPPORT FROM CHRISTIE & COWe are delighted, in our tenth year, to be adopted by loyal, long-term supporters, Christie & Co
November 2016THIRD YEAR GRANT TO DR JAMES DOWLINGWe are delighted to announce a third year of funding to further develop a very promising treatment option for myotubular myopathy
November 2016LATEST UPDATE ON CLINICAL TRIALSRead the latest updated FAQ from Audentes Therapeutics on MTM1 gene therapy clinical trials
Myotubular Myopathy is a rare genetic muscle condition that affects mostly boys from birth. The condition causes profound muscle weakness and most dangerously affects the muscles that control breathing and swallowing. Eighty per cent of children die before their first birthday. One per cent make it to ten years old*. For the last 10 years, the Myotubular Trust has lead the way in both supporting families and investing in research to find a treatment and a cure.
Now, thanks to our supporters, scientists the Trust has funded are on the verge of a breakthrough that could lead to a treatment for not only myotubular and centronuclear myopathy but other rare muscle diseases too.
Join us in changing the lives of the children and families who are affected by this rare disease. A cure or treatment is no longer a pipe dream - but only you can make it a reality.
This film has been made with the kind sponsorship of